tiprankstipranks
Trending News
More News >
Siemens Healthineers AG (DE:SHL)
XETRA:SHL
Germany Market

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

Compare
66 Followers
See the Price Targets and Ratings of:

SHL Analyst Ratings

Strong Buy
14Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€60.44
▲(31.17%Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €60.44 with a high forecast of €65.00 and a low forecast of €56.00. The average price target represents a 31.17% change from the last price of €46.08.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"44":"€44","55":"€55","66":"€66","49.5":"€49.5","60.5":"€60.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":65.0000002254993,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€65.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.4428600654,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€60.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56.00000019427632,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€56.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[44,49.5,55,60.5,66],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.92,48.310769248115335,49.70153849623066,51.092307744345995,52.48307699246133,53.873846240576654,55.26461548869199,56.65538473680732,58.046153984922654,59.43692323303798,60.82769248115331,62.21846172926864,63.60923097738397,{"y":65.0000002254993,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.92,47.96022000503077,49.00044001006154,50.04066001509231,51.080880020123075,52.121100025153844,53.16132003018461,54.20154003521539,55.24176004024615,56.281980045276924,57.322200050307686,58.36242005533846,59.40264006036923,{"y":60.4428600654,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.92,47.61846155340587,48.31692310681174,49.01538466021761,49.71384621362348,50.412307767029354,51.110769320435224,51.809230873841095,52.507692427246965,53.206153980652836,53.904615534058706,54.60307708746458,55.30153864087045,{"y":56.00000019427632,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.944,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.529,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.45,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.295,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.536,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.958,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.348,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.046,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.12,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.38,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.79,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.92,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€65.00Average Price Target€60.44Lowest Price Target€56.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:SHL
TipRanks AITipRanks
Not Ranked
TipRanks
€51
Buy
10.68%
Upside
Reiterated
07/12/25
Siemens Healthineers AG's strong financial performance and positive earnings call highlights are key strengths, balanced by bearish technical indicators and a high valuation. The company's effective cash flow management and lack of long-term debt are significant positives, while trade uncertainties and valuation concerns temper the outlook.
Bernstein
€59
Buy
28.04%
Upside
Reiterated
07/09/25
Siemens Healthineers AG (SEMHF) Receives a Buy from Bernstein
Jefferies
€60
Buy
30.21%
Upside
Reiterated
07/07/25
Siemens Healthineers AG (SEMHF) Gets a Buy from Jefferies
Deutsche Bank  Analyst forecast on DE:SHL
Falko FriedrichsDeutsche Bank
Deutsche Bank
€67€62
Buy
34.55%
Upside
Reiterated
07/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pro Medicus Limited (Other OTC: PMCUF) and Siemens Healthineers AG (Other OTC: SEMHF)
Barclays
€62€61
Buy
32.38%
Upside
Reiterated
06/27/25
Siemens Healthineers AG (SEMHF) Gets a Buy from Barclays
UBS
Hold
Reiterated
06/27/25
UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
J.P. Morgan Analyst forecast on DE:SHL
David AdlingtonJ.P. Morgan
J.P. Morgan
€60.5
Buy
31.29%
Upside
Reiterated
06/27/25
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Dexcom (NASDAQ: DXCM)
Citi
€66.5€62
Buy
34.55%
Upside
Reiterated
06/05/25
Citi Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
Berenberg Bank Analyst forecast on DE:SHL
Sam EnglandBerenberg Bank
Berenberg Bank
€57.8
Buy
25.43%
Upside
Reiterated
05/29/25
Berenberg Bank Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
AI Firm
€55
Buy
19.36%
Upside
Reiterated
05/23/25
DBS
€54€59
Buy
28.04%
Upside
Reiterated
05/15/25
Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook
DZ BANK AG Analyst forecast on DE:SHL
Unknown AnalystDZ BANK AG
Not Ranked
DZ BANK AG
Buy
Upgraded
05/15/25
Goldman Sachs Analyst forecast on DE:SHL
Richard FeltonGoldman Sachs
Goldman Sachs
€60€56
Hold
21.53%
Upside
Reiterated
05/09/25
Goldman Sachs Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
HSBC
€58
Buy
25.87%
Upside
Reiterated
05/08/25
HSBC Reiterates Buy Rating on Siemens Healthineers (SHL:GR) (SEMHF)HSBC analyst Sezgi Oezener reiterated a Buy rating and EUR58.00 price target on Siemens Healthineers (SHL:GR) (OTC: SEMHF).
Stifel Nicolaus Analyst forecast on DE:SHL
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
€65
Buy
41.06%
Upside
Reiterated
05/07/25
Strong Imaging Performance and Strategic Management Drive Positive Outlook for Siemens Healthineers AG
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DE:SHL
TipRanks AITipRanks
Not Ranked
TipRanks
€51
Buy
10.68%
Upside
Reiterated
07/12/25
Siemens Healthineers AG's strong financial performance and positive earnings call highlights are key strengths, balanced by bearish technical indicators and a high valuation. The company's effective cash flow management and lack of long-term debt are significant positives, while trade uncertainties and valuation concerns temper the outlook.
Bernstein
€59
Buy
28.04%
Upside
Reiterated
07/09/25
Siemens Healthineers AG (SEMHF) Receives a Buy from Bernstein
Jefferies
€60
Buy
30.21%
Upside
Reiterated
07/07/25
Siemens Healthineers AG (SEMHF) Gets a Buy from Jefferies
Deutsche Bank  Analyst forecast on DE:SHL
Falko FriedrichsDeutsche Bank
Deutsche Bank
€67€62
Buy
34.55%
Upside
Reiterated
07/07/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pro Medicus Limited (Other OTC: PMCUF) and Siemens Healthineers AG (Other OTC: SEMHF)
Barclays
€62€61
Buy
32.38%
Upside
Reiterated
06/27/25
Siemens Healthineers AG (SEMHF) Gets a Buy from Barclays
UBS
Hold
Reiterated
06/27/25
UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
J.P. Morgan Analyst forecast on DE:SHL
David AdlingtonJ.P. Morgan
J.P. Morgan
€60.5
Buy
31.29%
Upside
Reiterated
06/27/25
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Dexcom (NASDAQ: DXCM)
Citi
€66.5€62
Buy
34.55%
Upside
Reiterated
06/05/25
Citi Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
Berenberg Bank Analyst forecast on DE:SHL
Sam EnglandBerenberg Bank
Berenberg Bank
€57.8
Buy
25.43%
Upside
Reiterated
05/29/25
Berenberg Bank Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
AI Firm
€55
Buy
19.36%
Upside
Reiterated
05/23/25
DBS
€54€59
Buy
28.04%
Upside
Reiterated
05/15/25
Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook
DZ BANK AG Analyst forecast on DE:SHL
Unknown AnalystDZ BANK AG
Not Ranked
DZ BANK AG
Buy
Upgraded
05/15/25
Goldman Sachs Analyst forecast on DE:SHL
Richard FeltonGoldman Sachs
Goldman Sachs
€60€56
Hold
21.53%
Upside
Reiterated
05/09/25
Goldman Sachs Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
HSBC
€58
Buy
25.87%
Upside
Reiterated
05/08/25
HSBC Reiterates Buy Rating on Siemens Healthineers (SHL:GR) (SEMHF)HSBC analyst Sezgi Oezener reiterated a Buy rating and EUR58.00 price target on Siemens Healthineers (SHL:GR) (OTC: SEMHF).
Stifel Nicolaus Analyst forecast on DE:SHL
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
€65
Buy
41.06%
Upside
Reiterated
05/07/25
Strong Imaging Performance and Strategic Management Drive Positive Outlook for Siemens Healthineers AG
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

1 Month
xxx
Success Rate
10/18 ratings generated profit
56%
Average Return
+1.60%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +1.60% per trade.
3 Months
xxx
Success Rate
16/28 ratings generated profit
57%
Average Return
+2.94%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +2.94% per trade.
1 Year
Odysseas ManesiotisExane BNP Paribas
Success Rate
11/18 ratings generated profit
61%
Average Return
+2.63%
reiterated a buy rating 10 months ago
Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +2.63% per trade.
2 Years
xxx
Success Rate
12/18 ratings generated profit
67%
Average Return
+4.85%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +4.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
20
18
20
22
21
Hold
10
7
7
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
25
27
29
27
In the current month, SHL has received 21 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 60.44.
Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.53 with a range of €0.51 to €0.56. The previous quarter’s EPS was €0.56. SHL beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.06% of the time in the same period. In the last calendar year SHL has Preformed in-line its overall industry.
Next quarter’s earnings estimate for SHL is €0.53 with a range of €0.51 to €0.56. The previous quarter’s EPS was €0.56. SHL beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.06% of the time in the same period. In the last calendar year SHL has Preformed in-line its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €5.63B with a range of €5.56B to €5.82B. The previous quarter’s sales results were €5.91B. SHL beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year SHL has Preformed in-line its overall industry.
Next quarter’s sales forecast for SHL is €5.63B with a range of €5.56B to €5.82B. The previous quarter’s sales results were €5.91B. SHL beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year SHL has Preformed in-line its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 60.44.
    What is DE:SHL’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers AG has 31.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers AG a Buy, Sell or Hold?
          Siemens Healthineers AG has a consensus rating of Strong Buy, which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Siemens Healthineers AG’s share price target?
            The average share price target for Siemens Healthineers AG is 60.44. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €65.00 ,and the lowest forecast is €56.00. The average share price target represents 31.17% Increase from the current price of €46.08.
              What do analysts say about Siemens Healthineers AG?
              Siemens Healthineers AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers AG?
                To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis